Multicentric reticulohistiocytosis in a patient with malignant melanoma

A response to cyclophosphamide and a unique cutaneous feature

J. G. Kenik, Christopher Huerter, C. J. Huerter, J. A. Hurley, J. F. Stanosheck

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We describe a patient with multicentric reticulohistiocytosis and a history of malignant melanoma. His widely disseminated disease did not affect the site of surgical removal of the malignant melanoma nor the donor site of a skin graft. The multicentric reticulohistiocytosis progressed while the patient was taking nonsteroidal antiinflammatory agents, but showed significant response during a 10-month course of cyclophosphamide. While he was taking the cyclophosphamide, however, his melanoma recurred, and the patient subsequently died.

Original languageEnglish
Pages (from-to)1047-1051
Number of pages5
JournalArthritis and Rheumatism
Volume33
Issue number7
DOIs
StatePublished - 1990

Fingerprint

Cyclophosphamide
Melanoma
Skin
Non-Steroidal Anti-Inflammatory Agents
Tissue Donors
Transplants

All Science Journal Classification (ASJC) codes

  • Immunology
  • Rheumatology

Cite this

Multicentric reticulohistiocytosis in a patient with malignant melanoma : A response to cyclophosphamide and a unique cutaneous feature. / Kenik, J. G.; Huerter, Christopher; Huerter, C. J.; Hurley, J. A.; Stanosheck, J. F.

In: Arthritis and Rheumatism, Vol. 33, No. 7, 1990, p. 1047-1051.

Research output: Contribution to journalArticle

@article{f2061c4180914b70bd54219d36be23fa,
title = "Multicentric reticulohistiocytosis in a patient with malignant melanoma: A response to cyclophosphamide and a unique cutaneous feature",
abstract = "We describe a patient with multicentric reticulohistiocytosis and a history of malignant melanoma. His widely disseminated disease did not affect the site of surgical removal of the malignant melanoma nor the donor site of a skin graft. The multicentric reticulohistiocytosis progressed while the patient was taking nonsteroidal antiinflammatory agents, but showed significant response during a 10-month course of cyclophosphamide. While he was taking the cyclophosphamide, however, his melanoma recurred, and the patient subsequently died.",
author = "Kenik, {J. G.} and Christopher Huerter and Huerter, {C. J.} and Hurley, {J. A.} and Stanosheck, {J. F.}",
year = "1990",
doi = "10.1002/art.1780330720",
language = "English",
volume = "33",
pages = "1047--1051",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Multicentric reticulohistiocytosis in a patient with malignant melanoma

T2 - A response to cyclophosphamide and a unique cutaneous feature

AU - Kenik, J. G.

AU - Huerter, Christopher

AU - Huerter, C. J.

AU - Hurley, J. A.

AU - Stanosheck, J. F.

PY - 1990

Y1 - 1990

N2 - We describe a patient with multicentric reticulohistiocytosis and a history of malignant melanoma. His widely disseminated disease did not affect the site of surgical removal of the malignant melanoma nor the donor site of a skin graft. The multicentric reticulohistiocytosis progressed while the patient was taking nonsteroidal antiinflammatory agents, but showed significant response during a 10-month course of cyclophosphamide. While he was taking the cyclophosphamide, however, his melanoma recurred, and the patient subsequently died.

AB - We describe a patient with multicentric reticulohistiocytosis and a history of malignant melanoma. His widely disseminated disease did not affect the site of surgical removal of the malignant melanoma nor the donor site of a skin graft. The multicentric reticulohistiocytosis progressed while the patient was taking nonsteroidal antiinflammatory agents, but showed significant response during a 10-month course of cyclophosphamide. While he was taking the cyclophosphamide, however, his melanoma recurred, and the patient subsequently died.

UR - http://www.scopus.com/inward/record.url?scp=0025338741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025338741&partnerID=8YFLogxK

U2 - 10.1002/art.1780330720

DO - 10.1002/art.1780330720

M3 - Article

VL - 33

SP - 1047

EP - 1051

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -